KING OF PRUSSIA, Pa.-December 12, 2017-Greenphire, the global leader in financial software for clinical trials, announced today that Peachtree Bioresearch Solutions has selected eClinicalGPS to improve the accuracy, frequency and visibility of its investigator payment strategy. Peachtree Bioresearch Solutions is a full-service clinical research organization (CRO) that provides global clinical development services for emerging to mid-sized biotechnology, pharmaceutical, and medical device companies. “The site relationship is no different than any other business partnership. Ensuring our investigators are paid in a timely fashion with full transparency is critical to performance and fostering a close, trusting relationship,” said Kristy Nichols, President, CEO and Co-Founder of Peachtree. “Partnership and performance are at the heart of our clinical development services. A top-quality site payment process ensures we continue to provide our clients with efficient and cost-effective services.” There is an industry-wide movement to support monthly site payments. A recent study Greenphire conducted with the Society for Clinical Research Sites (SCRS) found that 84% of sites around the world would prefer payment in thirty days or less. Without a payment automation solution, increasing the frequency of site payments would have increased Peachtree’s operating costs by 400 percent. “The competitive landscape of the CRO market is demanding that these teams do more with less, making it critical to eliminate resource draining functions such as clinical grant payments,” explained Dave Espenshade, Vice President of CRO Partnerships. “Our partners choose our solution to reduce the manual process, but quickly see additional positive impacts in site performance and financial control – which is what sets our solution apart.” eClinicalGPS is the only automated site payment solution that is designed with the site perspective in mind, which is why it continues to be the financial software of choice for CROs and sponsors focused on site satisfaction and performance. The site-centric approach provides the most comprehensive visibility and control, eliminating any ambiguities or re-work alternative methods require. Greenphire’s implementation methodology for eClinicalGPS ensured the Peachtree team was up and running quickly, exceeding the team’s expectations. CROs and sponsors looking to support monthly site payments and transform their investigator payment strategy to be efficient, transparent and controlled, contact Greenphire. About Greenphire
Greenphire is the leader in global clinical trial payment automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more atwww.greenphire.com. About Peachtree
Founded in 2008, Peachtree BioResearch Solutions, Inc. is a Clinical Research Organization that specializes in providing clinical development services for emerging to mid-sized biotechnology, pharmaceutical, and medical device companies. With a highly-experienced clinical development team, Peachtree offers Clinical Project Management, Clinical Monitoring, Medical Monitoring, Biometrics (data management and statistical analysis), Technical Report Writing, Quality Assurance, and Clinical Staff Resourcing. Starting with one client at inception, Peachtree has grown its portfolio to over 65 clients providing services ranging from niche projects to full support.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.